Shen L, Qiu S, Chen Y, Zhang F, van Breemen R B, Nikolic D, Bolton J L
Department of Medicinal Chemistry and Pharmacognosy (M/C 781), College of Pharmacy, University of Illinois at Chicago, 60612-7231, USA.
Chem Res Toxicol. 1998 Feb;11(2):94-101. doi: 10.1021/tx970181r.
Premarin (Wyeth-Ayerst) is the estrogen replacement treatment of choice and continues to be one of the most widely dispensed prescriptions in the United States. In addition to endogenous estrogens, Premarin contains unsaturated estrogens including equilenin. We synthesized the catechol metabolite of equilenin, 4-hydroxyequilenin (4-OHEN), and found that the semiquinone radical of 4-OHEN reacted with 2'-deoxynucleosides generating very unusual adducts. 2'-Deoxyguanosine (dG), 2'-deoxyadenosine (dA), or 2'-deoxycytosine (dC) all gave four isomers, but no product was observed for thymidine under similar physiological conditions. The structures of these adducts were determined by electrospray mass spectrometry and NMR experiments including 1H, 13C, DQF-COSY, ROESY, HOHAHA, HMQC, and HMBC. The spectral data show that dG forms a cyclic adduct with the 4-OHEN producing 2-N1,3-N2-deoxyguanosyl-1,3-dihydroxy-5,7,9(10)-estratriene-4,17-d ione. Similarly, reaction with dA produced 1-N6,3-C2-deoxyadenosyl-2,3-dihydroxy-5,7,9(10)-estratriene-4,17-d ione, and incubations with dC resulted in 1-N3,3-N4-deoxycytosyl-2,3-dihydroxy-5,7,9(10)-estratriene-4,17-di one. We found that care needed to be taken during the isolation of the dA adducts in particular, as any exposure to acidic environments caused hydrolysis of the sugar moiety leaving alkylated adenine. In mixtures of the deoxynucleosides treated with 4-OHEN, reaction occurred primarily with dG followed by dC and dA. With DNA significant apurinic sites were produced as 4-OHEN-adenine adducts were detected in the ethanol wash prior to hydrolysis. When the DNA was hydrolyzed to deoxynucleosides and analyzed by electrospray mass spectrometry, only one isomer of 4-OHEN-dG and one isomer of 4-OHEN-dC were observed. Our data suggest that several different types of DNA lesions could be expected from 4-OHEN including apurinic sites and bulky stable adducts, in addition to the published oxidized damage to DNA caused by 4-OHEN. The production of these semiquinone radical-derived DNA adducts could play a role in the carcinogenic effects of Premarin estrogens.
倍美力(惠氏-艾尔斯特公司生产)是雌激素替代治疗的首选药物,并且一直是美国处方量最大的药物之一。除内源性雌激素外,倍美力还含有包括马萘雌酮在内的不饱和雌激素。我们合成了马萘雌酮的儿茶酚代谢物4-羟基马萘雌酮(4-OHEN),发现4-OHEN的半醌自由基与2'-脱氧核苷反应生成了非常特殊的加合物。2'-脱氧鸟苷(dG)、2'-脱氧腺苷(dA)或2'-脱氧胞苷(dC)均生成了四种异构体,但在相似生理条件下,胸苷未生成产物。这些加合物的结构通过电喷雾质谱和核磁共振实验确定,包括1H、13C、双量子滤波相关谱(DQF-COSY)、旋转坐标系核Overhauser效应谱(ROESY)、全同核Hartmann-Hahn谱(HOHAHA)、异核多量子相干谱(HMQC)和异核多键相关谱(HMBC)。光谱数据表明,dG与4-OHEN形成了环状加合物,生成了2-N1,3-N2-脱氧鸟苷基-1,3-二羟基-5,7,9(10)-雌甾三烯-4,17-二酮。同样,与dA反应生成了1-N6,3-C2-脱氧腺苷基-2,3-二羟基-5,7,9(10)-雌甾三烯-4,17-二酮,与dC孵育则生成了1-N3,3-N4-脱氧胞苷基-2,3-二羟基-5,7,9(10)-雌甾三烯-4,17-二酮。我们发现,在分离dA加合物时尤其需要小心,因为任何暴露于酸性环境都会导致糖部分水解,留下烷基化腺嘌呤。在用4-OHEN处理的脱氧核苷混合物中,反应主要发生在dG上,其次是dC和dA。对于DNA,会产生大量无嘌呤位点,因为在水解前的乙醇洗涤液中检测到了4-OHEN-腺嘌呤加合物。当DNA水解为脱氧核苷并通过电喷雾质谱分析时,仅观察到一种4-OHEN-dG异构体和一种4-OHEN-dC异构体。我们的数据表明,除了已报道的4-OHEN对DNA造成的氧化损伤外,4-OHEN还可能导致几种不同类型的DNA损伤,包括无嘌呤位点和大的稳定加合物。这些半醌自由基衍生的DNA加合物的产生可能在倍美力雌激素的致癌作用中发挥作用。